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overexpression of p53 reduced levels of LC3B-II, supporting 
a negative regulatory role on autophagy in differentiating 
trophoblasts. This was also shown in primary trophoblasts 
and human first trimester placental explants, where phar-
macological stabilization of p53 decreased LC3B-II levels. 
In summary our data suggest that differentiation-depend-
ent downregulation of p53 is a prerequisite for activating 
autophagy in the syncytiotrophoblast.
Keywords Pregnancy · Placenta · Development · 
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Introduction
The placenta is responsible for pregnancy-maintaining func-
tions, such as exchange of gases and metabolites, secretion 
of essential hormones, and regulation of water balance. Pla-
cental villi are covered by a continuous layer of a multinu-
cleated trophoblast, referred to as syncytiotrophoblast, and 
underlying mononucleated cytotrophoblasts. Together they 
form a major part of the placental barrier, which is main-
tained by a unique cellular turnover: a small subset of mitoti-
cally active progenitors among the cytotrophoblast popula-
tion divides in an asymmetric way, generating one daughter 
cell with a preserved proliferation-competent status and a 
second that escapes the cell cycle. These post-mitotic cells 
undergo differentiation and finally fuse with the syncytio-
trophoblast. Trophoblast differentiation and fusion are regu-
lated by multiple factors, including cytokines, hormones, 
protein kinases, transcription factors, proteases, and mem-
brane proteins [17], although most of these factors are in 
fact not bona fide fusogens [16]. Upon fusion, isolated short 
fragments of plasma membrane can be observed within the 
syncytioplasm and are presumably recycled in due time [4].
Abstract The placental barrier is crucial for the sup-
ply of nutrients and oxygen to the developing fetus and is 
maintained by differentiation and fusion of mononucleated 
cytotrophoblasts into the syncytiotrophoblast, a process only 
partially understood. Here transcriptome and pathway analy-
ses during differentiation and fusion of cultured trophoblasts 
yielded p53 signaling as negative upstream regulator and 
indicated an upregulation of autophagy-related genes. We 
further showed p53 mRNA and protein levels decreased dur-
ing trophoblast differentiation. Reciprocally, autophagic flux 
increased and cytoplasmic LC3B-GFP puncta became more 
abundant, indicating enhanced autophagic activity. In line, in 
human first trimester placenta p53 protein mainly localized 
to the cytotrophoblast, while autophagy marker LC3B as 
well as late autophagic compartments were predominantly 
detectable in the syncytiotrophoblast. Importantly, ectopic 
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One mechanism participating in disassembly of residual 
plasma membrane and in cytoskeleton rearrangement in 
trophoblast syncytialization can be macroautophagy (hereaf-
ter referred to as autophagy). As a cell survival process gen-
erally important for degradation of aggregates of misfolded 
proteins or damaged organelles, autophagy is responsible for 
intracellular ‘revitalization’, which seems to be particularly 
important for the maintenance of terminally differentiated 
cells [34]. In the context of remodeling and differentiation, 
the catabolic degradation of cellular components represents 
a crucial source of metabolites and precursor molecules 
required in anabolic processes [33]. Accordingly, autophagy 
is ascribed fundamental roles in the differentiation of vari-
ous cell types, including hematopoietic cells [41], myoblasts 
[14], lens epithelial cells [3], and epidermal keratinocytes 
[2]. In human placenta, autophagy is described to protect the 
syncytiotrophoblast from apoptosis [53], bacterial infection 
[8], and inflammation [58]. Although some signaling hubs, 
such as mechanistic target of rapamycin (mTOR) and 5′ 
adenosine monophosphate-activated protein kinase (AMPK) 
are well described in regulating (placental) autophagy, many 
questions still remain regarding precise mechanisms ensur-
ing autophagic flux in the course of human trophoblast dif-
ferentiation and fusion.
Here, the trophoblast cell line BeWo was used to study 
expression of autophagy-related genes and their upstream 
regulators during trophoblast differentiation. Transcriptome 
analyses showed considerable upregulation of autophagy-
relevant genes in differentiated trophoblasts and identified 
p53 as a putative negative upstream regulator. Based on 
these initial observations, the hypothesis whether p53 regu-
lates autophagy in human trophoblast differentiation was 
addressed in several experimental systems.
Results
Global transcriptome characterization of BeWo 
differentiation
The trophoblast cell line BeWo was used as in vitro model 
to study global transcriptome changes in villous trophoblast 
differentiation. For this purpose, BeWo cells were cultured 
for 48 h in the presence or absence of forskolin, a compound 
well-described to induce syncytiotrophoblast formation 
[54]. First, syncytialization and endocrine differentiation of 
forskolin-stimulated BeWo cells were confirmed by immu-
nofluorescence staining of E-cadherin and by measuring of 
mRNA expression of β subunit of human chorionic gon-
adotropin (CGB). E-cadherin staining showed that vehicle 
control cells remained mononucleated (Fig. 1a), whereas 
forskolin induced pronounced formation of multinucleated 
syncytia (Fig. 1b). Syncytialization was accompanied by a 
20.7-fold increase in CGB expression, when compared to 
vehicle control (Fig. 1c). After having confirmed differentia-
tion and syncytialization, mRNA from forskolin-stimulated 
and vehicle control BeWo cells was subjected to differen-
tial microarray analysis and controls. This yielded to 1183 
upregulated and 1460 downregulated genes that are at least 
changed twofold. Top upregulated genes contain marker 
genes of ‘syncytiotrophoblastogenesis’, such as several iso-
forms of CGB [31], or placental growth factor (PGF) [12], 
verifying the plausibility of our data. To analyze this data set 
on pathway and gene ontology (GO) levels, we used ingenu-
ity pathway analysis (IPA) and DAVID functional annota-
tion, respectively (Fig. 1d). IPA includes data-based predic-
tion of potential upstream regulators. The top five regulators 
with a positive and a negative activation z-score are shown 
in Fig. 1e.
Consistent with the treatment applied, forskolin was 
identified as highly significant activating regulator. Other 
regulators with positive z-score were epidermal growth 
factor (EGF), TNF, lipopolysaccharide (LPS), and dexa-
methasone, all of which were reported to participate in 
placenta development or fusion in other cell systems [23, 
36, 50, 56]. Interestingly, p53 was among the top nega-
tive regulators (Fig. 1e). While the expression of p53 has 
been investigated in placental samples [19, 21, 44] and in 
the context of trophoblast invasion [35, 49], it has not been 
described as regulator in villous trophoblast differentiation. 
Besides being a prominent tumor suppressor in cancer cells, 
p53 is known to play a role in autophagy regulation [30]. 
Consistently, performing DAVID functional annotation on 
the upregulated genes yielded the GO biological process 
“autophagy” (GO:0006914) as one of many significantly 
overrepresented GO terms. The expression levels of genes 
contained in the autophagy GO term are depicted as heat 
map in Fig. 1f, showing upregulation of many autophagy-
related genes (ATGs), as well as autophagosomal (SQSTM1, 
also known as p62) and lysosomal (LAMP1) markers. In 
summary, our analyses revealed autophagy as upregulated 
during trophoblast differentiation, while p53 appeared as a 
negative regulator of this process.
p53 is downregulated during trophoblast differentiation
We further scrutinized the role of p53 as negative regula-
tor during trophoblast differentiation and syncytialization. 
Forskolin-induced differentiation of BeWo cells was accom-
panied with a 2.9-fold decrease of p53 mRNA levels, when 
compared to vehicle control after 48 h culture (Fig. 2a). In 
line with mRNA data, p53 protein declined by 47.6% in 
forskolin-treated BeWo cells, compared to control (Fig. 2b, 
c). Immunocytochemical staining of non-stimulated BeWo 
cells, i.e., cells incubated with vehicle control alone, showed 
abundant p53 staining in the majority of nuclei (Fig. 2d). 
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However, when cells were cultured in the presence of forsko-
lin, the number of p53 positive nuclei significantly declined 
by 35.6% (Fig. 2e, g).
Our observations in BeWo culture reflected the in situ 
situation, as determined by immunohistochemistry of human 
first trimester and term villous placental tissue. In first tri-
mester placental villi, p53 was detected in nuclei of most vil-
lous cytotrophoblasts, whereas nuclei in the overlying syn-
cytiotrophoblast showed only weak to no staining (Fig. 2h). 
This pattern was also detected in term placenta, showing 
strong p53 staining in the rare cytotrophoblast population 
and only scant staining in the syncytiotrophoblast (Fig. 2i).
Autophagy markers p62 and LC3B‑II increase 
during trophoblast differentiation
To test whether trophoblast differentiation is accompanied 
by induction of autophagy as suggested by our transcriptome 
analyses, the effects of forskolin stimulation on autophagy 
markers p62 and LC3B were analyzed in BeWo cells and 
human first trimester placenta. Accordingly, forskolin treat-
ment of BeWo cells showed 1.9- and 4.3-fold increased p62 
mRNA (Fig. 3a) and protein levels (Fig. 3b, c), respectively, 
when compared to control. Also, immunohistochemistry of 
human first trimester placenta revealed a distinct, spotted 
Fig. 1  Transcriptome analyses of BeWo cell differentiation. Immu-
nofluorescence staining of E-cadherin in BeWo cells incubated 
either with vehicle control (a, DMSO, 0.1%) or forskolin (b, 20 µM). 
Stimulation with forskolin induced formation of multinucleated syn-
cytia (outlined by dotted lines) after 48  h culture. Scale bar in (b) 
represents 100  µm. c qPCR analysis showed significantly upregu-
lated mRNA expression of β subunit of human chorionic gonadotro-
pin (CGB) in forskolin-treated BeWo cells after 48 h. Data are pre-
sented as mean ± SEM *p ≤ 0.05. d Bioinformatic pipeline applied 
to twofold regulated genes is depicted. e Top five positive (positive 
z-score) and negative (negative z-score) upstream regulators derived 
from ingenuity pathway analysis (IPA), sorted by adjusted p values 
given next to bars. f Heatmap of genes comprising the gene ontol-
ogy (GO) term “autophagy” that is significantly enriched (adjusted p 
value = 7.9E−3) in a DAVID functional annotation analysis focused 
on GO biological processes. Data are from three independent experi-
ments, using different cell passages
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staining pattern for p62 in the syncytiotrophoblast, whereas 
the villous cytotrophoblast layer showed only a pale homo-
geneous staining (Fig. 3d).
While p62 upregulation confirmed our microar-
ray data (Fig. 1f), we used LC3 as autophagy marker in 
further analyses. This was informed by the state-of-the-art 
autophagy guidelines [26] that also establish lipidation 
of endogenous LC3B via western blot, in combination 
with autophagy inhibitors, as the most reliable indicator 
of autophagosome turnover (i.e. autophagic flux). Gene 
Fig. 2  p53 expression in BeWo 
differentiation and human vil-
lous placenta. qPCR analysis 
(a) and immunoblotting (b) 
with subsequent band densitom-
etry (c), showed significantly 
downregulated p53 mRNA 
and protein, respectively, in 
forskolin treated (20 µM) BeWo 
cells, compared to vehicle 
control (DMSO, 0.1%) after 
48 h. Immunocytochemistry of 
BeWo cells treated with vehicle 
only (DMSO, 0.1%) detected 
p53 in a considerable proportion 
of nuclei (d), while stimula-
tion with forskolin (20 µM, 
48 h) decreased the amount 
of positive stained nuclei (e). 
Incubation with negative control 
mouse IgG2a yielded no stain-
ing in BeWo (f). Nuclear p53 
staining was quantified using 
a cell image analysis software 
(g). Immunohistochemistry of 
human first trimester (h) and 
term placenta (i) located p53 in 
nuclei of cytotrophoblasts (open 
arrowheads), whereas nuclei 
within the syncytiotrophoblast 
showed only scant staining 
(arrowheads). Scale bar in f 
represents 100 µm and in h and 
i 50 µm. Data in a and c are 
presented as mean ± SEM from 
four and six independent experi-
ments, respectively, using dif-
ferent cell passages. **p ≤ 0.01, 
***p < 0.001
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expression analysis of the LC3B gene MAP1LC3B did not 
show any significant deregulation in response to forskolin 
after 48 h incubation (Fig. 3e). However, on protein level, 
the posttranslationally processed variant LC3B-II, which 
undergoes lipidation with phosphatidylethanolamine and 
binds to the outer membrane of autophagosomes, signifi-
cantly increased 3.3-fold, while non-lipidated cytosolic 
LC3B-I remained unchanged, when compared to vehicle 
control (Fig. 3f–h). Thus, the ratio of LC3B-II to LC3B-
I significantly increased during forskolin-induced BeWo 
differentiation (Fig. 3i). Immunofluorescence double stain-
ing of human first trimester placenta showed a reciprocal 
staining pattern of p53 and LC3 in the double-layered 
villous trophoblast compartment. While p53 was pre-
dominantly located in nuclei of villous cytotrophoblasts 
(Fig. 3j), LC3 was detected in the apical cytoplasmic part 
of the syncytiotrophoblast (Fig. 3k). Apical LC3 localiza-
tion in the syncytiotrophoblast was in good agreement with 
subsequent transmission electron microscopy (TEM) anal-
ysis of human first trimester placenta (Fig. 3m), showing 
structures reminiscent of late autophagic compartments, 
i.e., late autophagolysosomes, directly underneath the 
microvillous plasma membrane of the syncytiotrophoblast 
Fig. 3  p62 and LC3B expression in BeWo differentiation and 
human villous placenta. qPCR analysis of p62 mRNA (a, SQSTM1), 
immunoblotting (b) and band densitometry (c) showed significantly 
increased p62 levels after 48  h incubation with forskolin (20  µM), 
when compared to vehicle control (DMSO, 0.1%). Immunohisto-
chemistry of human first trimester placenta (d) located p62 in the 
syncytiotrophoblast (arrowhead), whereas cytotrophoblasts (open 
arrowhead) showed only weak staining. qPCR analysis of LC3B 
mRNA (MAP1LC3B) did not show significant differences between 
forskolin-treated (20 µM) BeWo cells and vehicle control after 48 h 
(e). Immunoblotting (f) and band densitometry revealed no differ-
ence in LC3B-I levels (g), whereas LC3B-II levels (h) and the ratio 
of LC3B-II to LC3B-I (i) significantly increased in response to for-
skolin (20  µM, 48  h). Immunofluorescence double staining showed 
p53 staining in nuclei of villous cytotrophoblasts (j, open arrowhead), 
while LC3 staining was predominantly detected in apical regions 
of the syncytiotrophoblast (k, arrowhead). Merge of p53 and LC3 
immunofluorescence is shown in (l). Transmission electron micros-
copy (TEM) analysis of human first trimester villous cytotrophoblast 
(m, open arrowhead) and syncytiotrophoblast (m, arrowhead) showed 
late autophagic compartments underneath the microvillous plasma 
membrane of the syncytiotrophoblast (n, o), whereas the cytoplasm 
of villous cytotrophoblasts (p) were devoid of such structures. Scale 
bars in d and l represent 50 µm. Scale bar in m represents 5000 nm 
and those in n–p 1000 nm. Data in a–e and those in f–i are presented 
as mean ± SEM from three and six independent experiments, respec-
tively, using different cell passages. *p ≤ 0.05, **p ≤ 0.01
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(Fig. 3n, o), whereas the cytoplasm of villous cytotropho-
blasts was devoid of such structures (Fig. 3p).
Autophagic activity is enhanced during trophoblast 
differentiation
The fact that LC3B-II levels significantly increased in 
BeWo cells upon forskolin stimulation, while LC3B gene 
expression remained stable, indicates either a blockage of 
autophagy (thereby leading to accumulation of LC3B-II) 
or increased autophagic activity during trophoblast dif-
ferentiation [26]. Autophagic activity (or flux) is usually 
determined by measuring cellular LC3B-II turnover in the 
presence or absence of leupeptin, a membrane-permeable 
thiol protease inhibitor that blocks autophagy by impairing 
amphisome–lysosome fusion [20]. Since lysosomes are the 
dominant site of LC3B-II clearance, leupeptin administra-
tion mediates LC3B-II accumulation through attenuated 
lysosomal decay. In BeWo cells, leupeptin administration 
further augmented forskolin-induced increase of LC3B-II 
levels (Fig. 4a), which were increased by 59% compared to 
forskolin treatment alone (Fig. 4b). Interestingly, leupep-
tin per se increased low LC3B-II levels in vehicle control 
cells by 63%, which did not reach statistical significance, 
but suggested some extent of basal autophagic activity in 
non-stimulated BeWo cells (Fig. 4a, b).
These observations were confirmed by transfection of 
BeWo cells with a LC3B-GFP construct, generating green 
cytoplasmic LC3B puncta depending on the stimulation and 
degree of autophagic activity. In line with LC3B-II immu-
noblot data, control BeWo cells showed moderate levels 
of LC3B puncta (Fig. 4c), which increased after leupeptin 
treatment (Fig. 4d). However, when cells were stimulated 
with forskolin, LC3B puncta increased compared to vehicle 
control (Fig. 4e), and further increased after both forsko-
lin and leupeptin administration (Fig. 4f), as determined 
by software-based image segmentation and pixel counting 
(Fig. 4g).
Prevention of p53 decrease reduces autophagic activity 
in trophoblast differentiation
To test whether downregulation of p53 is connected to 
increased autophagy in trophoblasts, we aimed to retain 
p53 levels during differentiation by ectopic expression. 
While transfection with empty vector and subsequent for-
skolin treatment again showed significant downregulation 
of p53 protein, p53 overexpression completely abrogated 
forskolin-induced downregulation of p53 and showed no sig-
nificant difference in p53 protein levels between forskolin 
stimulation and vehicle control (Fig. 5a, b). However, over-
expression of p53 significantly reduced LC3B-II levels in 
forskolin-stimulated BeWo cells by 40.7%, when compared 
to forskolin-treated empty vector control (Fig. 5c). Interest-
ingly, markers of villous trophoblast differentiation, such 
as expression of transcription factor GCM1 (Fig. 5d) and 
its downstream targets syncytin-1 (ERVW-1, Fig. 5e) and 
syncytin-2 (ERVFRD-1, Fig. 5f) as well as expression and 
secretion of human chorionic gonadotropin (hCG) beta-sub-
unit (Fig. 5g, h), were not affected by ectopic overexpression 
of p53—neither in forskolin-stimulated cells nor in controls. 
These data suggested that activation of autophagy is spe-
cifically blocked by circumvention of p53 downregulation, 
while trophoblast differentiation is unaffected.
To show that observed effects of p53 on autophagy in 
trophoblast differentiation are independent of forskolin treat-
ment; levels of p53 and autophagy marker LC3B-II were 
analyzed in primary term trophoblast. Analysis of culture 
supernatants showed a time-dependent increase in βhCG 
secretion (Fig. 6a), confirming spontaneous differentiation 
of primary trophoblast. Immunoblotting for p53 protein 
revealed a double band. While the upper band remained 
largely unchanged in our experimental conditions, the lower 
declined during culture (Fig. 6b) and increased in presence 
of Nutlin-3a (Fig. 6f)—a compound that stabilizes p53 by 
competitively inhibiting its interaction with Mdm2, and 
thereby prevents its proteasomal degradation [52]. Thus, 
only the lower band was considered as specific for p53. 
Respective band densitometry showed that p53 levels sig-
nificantly declined by 46% in primary trophoblasts after 48 h 
culture (Fig. 6b, c), while at the same time LC3B-II levels 
increased 5.1-fold (Fig. 6b, d). Further, leupeptin treatment 
substantially increased LC3B-II after 48 h (Fig. 6e), suggest-
ing active autophagic flux in cultured primary trophoblasts. 
However, when primary trophoblasts were cultured in the 
presence of Nutlin-3a, increased p53 levels were accompa-
nied by a remarkable decrease of LC3B-II after 48 h culture 
(Fig. 6f).
Nutlin‑mediated p53 stabilization decreased LC3B‑II 
levels in placental explants
Next, we compared data from BeWo cell model and primary 
trophoblasts to placental explant culture—an in vitro model 
which may be considered as more physiologic since villous 
trophoblasts remain in their natural microenvironment. For 
this purpose human first trimester placental explants were 
first incubated with or without leupeptin, and p53 as well 
as LC3B-II protein levels determined with immunoblot-
ting. While p53 remained unchanged (Fig. 7a, b), LC3B-II 
levels showed a trend to increase in presence of leupeptin, 
which, however, did not reach statistical significance, when 
compared to control (Fig. 7a, c). Interestingly, levels of pla-
cental LC3B-II were consistently stronger than LC3B-I, irre-
spective of treatment. Together, these data suggested basal 
autophagic activity in cultured placental explants.
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Fig. 4  Autophagic activity 
is increased in BeWo dif-
ferentiation. Immunoblotting 
(a) and band densitometry (b) 
showed that leupeptin (100 µM) 
treatment further augmented 
forskolin-induced (20 µM, 48 h) 
increase of LC3B-II levels, 
when compared to forskolin 
treatment alone. Transfection of 
BeWo cells with a LC3B-GFP 
construct showed moder-
ate LC3B puncta in vehicle 
control (c, DMSO, 0.1%), 
which increased after leupeptin 
(100 µM) treatment (d). For-
skolin stimulation (e) increased 
LC3B puncta compared to 
vehicle control, and further 
increased after both forskolin 
and leupeptin administration (f). 
Software-based image analysis 
of LC3B-GFP puncta (g) by 
trend confirmed data obtained 
with immunoblotting. Scale bar 
in c represents 50 µm. Data in b 
are presented as mean ± SEM 
from three independent experi-
ments, using different cell pas-
sages. *p ≤ 0.05
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In contrast, incubation with Nutlin-3a showed 4.1-fold 
increased placental p53 levels, when compared to control 
(Fig. 7d, e). Stabilization of placental p53 levels by Nutlin-
3a was accompanied by a 25.4% decrease in LC3B-II levels. 
Additionally, immunohistochemistry of placental explants 
showed increased p53 staining intensity of villous cyto-
trophoblast nuclei after incubation with Nutlin-3a (Fig. 7h), 
compared to control. Interestingly, nuclei of the syncytio-
trophoblast remained unstained in response to Nutlin-3a, 
suggesting that p53 downregulation and/or proteasomal 
degradation may precede fusion and occurs already in the 
underlying cytotrophoblast.
Forskolin had no effect on p53 and autophagy 
in non‑fusing JAR trophoblasts
Finally, effects observed for fusion-competent BeWo cells 
were compared to non-fusing trophoblast cell line JAR [6]. 
Immunofluorescence staining of JAR cells for transmem-
brane protein E-cadherin did not show formation of syncytia 
(i.e., multinucleated cells) in response to forskolin treatment 
after 48 h (Fig. 8a, b). In this cell line, forskolin stimulation 
had no significant effect on p53 and LC3B mRNA expres-
sion, respectively (Fig. 8c, d). In line with mRNA data, 
p53 protein levels did not change upon forskolin treatment 
Fig. 5  p53 overexpression 
reduced autophagic activity in 
BeWo differentiation. BeWo 
cells were transfected either 
with a p53 expressing vector 
(+p53 OE) or empty vector 
control (−p53 OE) and were 
subsequently incubated with 
forskolin (20 µM) or vehicle 
control (DMSO, 0.1%), respec-
tively, for 48 h. Immunoblot (a) 
and band densitometry data for 
p53 (b) and LC3B-II (c) levels 
showed that p53 overexpression 
abrogated forskolin-mediated 
downregulation of endogenous 
p53 and at the same time signif-
icantly reduced LC3B-II levels 
compared to forskolin-stimu-
lated empty vector control. p53 
overexpression did not affect 
forskolin-induced expression 
of GCM1 (d), syncytin-1 (e, 
ERVW-1), syncytin-2 (f, ERV-
FRD-1), as well as expression 
(g, CGB) and secretion (h) of 
hCG-beta subunit. Data in b–h 
are presented as mean ± SEM 
from three independent experi-
ments, using different cell pas-
sages. Significant differences 
between p53 overexpression 
(+p53 OE) and empty vector 
control (−p53 OE) in forskolin-
stimulated cells are indicated 
*p ≤ 0.05
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(Fig. 8e, f). Analysis of LC3B protein showed stronger 
LC3B-I than LC3B-II levels, suggesting minimal autophagic 
activity in JAR cells under basal conditions (Fig. 8e). In the 
presence of forskolin, both LC3B-I and LC3B-II levels were 
slightly but not significantly increased, whereas the ratio of 
LC3B-II to LC3B-I remained unchanged (Fig. 8g–i).
Discussion
Here, we provide evidence that p53 regulates autophagic 
activity in human villous trophoblasts. Once trophoblasts 
undergo differentiation and fuse with the multinucleated 
syncytium, p53 levels decline while autophagic activity 
increases. Activated autophagy during trophoblast differen-
tiation is in agreement with a recent study by Cao et al. that 
shows increased levels of LC3B-II in forskolin-treated BeWo 
cells and suggests that autophagy levels positively correlate 
with syncytialization [8]. Our data show reciprocal levels 
of p53 and LC3B-II protein not only in forskolin-induced 
BeWo cells but also in primary trophoblasts undergoing 
spontaneous differentiation, suggesting a forskolin-inde-
pendent effect. Most importantly, we show in BeWo cells, 
primary trophoblasts, and placental explants that preventing 
the decrease in p53 levels, via ectopic overexpression or 
pharmacological stabilization with Nutlin-3a, significantly 
reduces autophagy marker LC3B-II, indicating that p53 
downregulation is a conditio sine qua non for functional 
autophagy in the syncytiotrophoblast. Consistent with our 
in vitro results, p53 is strongly reduced in the syncytiotroph-
oblast layer, while showing high levels of p53 staining in 
cytotrophoblast nuclei.
p53 has been attributed an important role in stem cell dif-
ferentiation: human induced pluripotent stem cells (iPSCs) 
differentiate into several lineages with much higher effi-
ciency when p53 is artificially downregulated via RNAi 
[25], presumably by alleviating p53’s cell cycle arrest and 
senescence activity [48]. In particular, p53 knockdown in 
iPSCs enhanced the rate of lineage conversion into tropho-
blast stem cells [27]. Furthermore, impaired repression of 
p53 levels in SENP2 knockout mice impedes trophoblast 
development [10]. However, in our study, overexpression of 
p53 during BeWo differentiation did not influence expres-
sion of differentiation markers and βhCG secretion, indicat-
ing that reduced p53 levels in the syncytiotrophoblast are a 
prerequisite for autophagy but not for differentiation per se. 
It is conceivable that the reports in iPSCs and in SENP2-
knockout mice reflect p53’s action on lineage commitment 
very early in stem cell development, while BeWo cells and 
isolated primary trophoblasts are pre-committed cells with 
different specifics of p53 signaling.
Deletion, depletion, or inhibition of p53 has previously 
been associated with signs of induced autophagy, includ-
ing conversion of LC3-I to LC3-II, redistribution of LC3B-
GFP in cytoplasmic puncta and autophagosome formation 
[30]. Accordingly, colon cancer cells, human fibroblasts, 
Fig. 6  p53 and autophagic 
activity in primary tropho-
blast culture. Primary term 
trophoblasts were seeded 1 day 
prior to time point 0 h. Culture 
supernatants and cell lysates 
were collected at indicated time 
points. a Secretion of βhCG 
increased over time and sug-
gested spontaneous differentia-
tion of cultured trophoblasts. 
Immunoblotting (b) and band 
densitometry showed declin-
ing p53 levels (c), while 
LC3B-II levels (d) increased 
during culture. Incubation of 
trophoblasts with leupeptin 
(100 µM) did not change p53 
protein, whereas LC3B-II 
levels (e) increased after 48 h 
incubation. Nutlin-3a treatment 
(10 µM, 48 h) increased p53 
and decreased LC3B-II levels 
(f) when compared to control. 
Data in a, c and d are presented 
as mean ± SEM from three dif-
ferent trophoblast preparations. 
*p ≤ 0.05
1848 M. Gauster et al.
1 3
and neuroblastoma cells show accumulation of autophago-
somes and increased LC3B-II levels when p53 is silenced 
by siRNA, knocked out by homologous recombination, 
or inhibited by the p53 antagonist pifithrin-α [51]. We 
speculated about the consequence of p53 knockdown on 
autophagic activity during BeWo differentiation, but real-
ized that cell seeding density required for siRNA transfec-
tion does not allow appropriate formation of syncytia. This 
obstacle has previously been shown for myocytes, which 
did not fuse into myotubes due to very low cell density [15].
Based on our results and our proposed role of p53 in 
repressing autophagy in villous trophoblasts, it is tempting 
to speculate about an association of abnormal p53 levels 
and dysregulated autophagy in placenta pathologies. Indeed, 
autophagy is described to occur in the syncytiotrophoblast 
of normal human placenta and is enhanced in placentas 
from pregnancies complicated by preeclampsia (PE) and/
or intrauterine growth restriction (IUGR). Accordingly, 
immunoblotting for LC3B-II and electron microscopy indi-
cate elevated autophagy levels in placentas from cases of PE 
[1, 24, 55] and IUGR [11, 22]. Although the available data 
for p53 in placental pathologies are inconsistent, they alto-
gether suggest aberrant levels in pregnancies complicated by 
PE and IUGR. Previous expression analyses show signifi-
cant higher p53 levels in placental tissue from IUGR cases 
[22, 42], in which most pronounced differences in p53 were 
Fig. 7  Nutlin-3a increased p53 
and reduced LC3B-II levels in 
placental explants. Incubation 
of human first trimester pla-
cental explants with leupeptin 
(100 µM) and subsequent 
immunoblotting (a) showed 
unchanged p53 protein (b) and 
increased LC3B-II levels (c) 
after 48 h incubation, suggest-
ing basal autophagic activity 
in placental explant culture. 
Nutlin-3a treatment (10 µM, 
48 h) substantially increased 
placental p53 levels, whereas 
LC3B-II levels at the same time 
declined when compared to 
solvent control (d, e, f). Immu-
nohistochemistry of control (g) 
and Nutlin-3a treated placental 
explants (h) revealed increased 
p53 staining intensity of villous 
cytotrophoblast nuclei (open 
arrowhead), while nuclei of the 
syncytiotrophoblast (arrowhead) 
remained unstained in response 
to Nutlin-3a. Scale bar in h rep-
resents 100 µm. Data in b and c 
are presented as mean ± SEM 
from three and those in e and 
f from four different patients. 
*p ≤ 0.05
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observed in cytotrophoblast nuclei [28]. In severe early onset 
PE, p53 protein was shown to be significantly decreased, 
whereas no changes could be detected on mRNA level [42]. 
In contrast, other studies show significantly increased p53 
protein in PE cases [37, 44], while another recent report 
shows decreased placental p53 mRNA levels in PE, PE asso-
ciated with IUGR and in cases with IUGR only [13]. These 
inconsistencies may be explained by low case numbers, dif-
ferences in gestational age at delivery, and different severity 
of pathology and call for further studies.
The dominant mechanism for regulating wild-type p53 
at the post-transcriptional level is via its interaction with 
the endogenous inhibitor Mdm2 [32], an E3-ubiquitin 
ligase known to ubiquitinate p53 to target it for proteaso-
mal degradation. Thus, aberrant placental p53 protein lev-
els, with unchanged p53 mRNA expression as described 
by some studies for PE and IUGR cases, can be explained 
by regulation of p53 protein stability via Mdm2 or similar 
E3 ubiquitin ligases. Since p53 is mainly regulated post-
transcriptionally in most cells, much less is known about 
mechanisms of p53 regulation on the transcriptional level. 
However, in different cell systems, p53 mRNA levels have 
been shown to be regulated by adjusting the rate of transcrip-
tion (histone deacetylases (HDAC9, [59]), by modulation of 
Fig. 8  Effect of forskolin on 
p53 and autophagy in non-fus-
ing JAR trophoblasts. Immuno-
fluorescence staining of E-cad-
herin in JAR cells incubated 
either with vehicle control (a, 
DMSO, 0.1%) or forskolin (b, 
20 µM) did not show formation 
of multinucleated syncytia after 
48 h culture. qPCR analysis of 
p53 (c) and LC3B (d) mRNA 
as well as immunoblotting (e) 
with subsequent band densitom-
etry for p53 (f), LC3B-I, and 
LC3B-II (g–i) protein levels did 
not show significant differences 
between forskolin (20 µM) 
treated JAR cells and vehicle 
control (DMSO, 0.1%) after 
48 h. Scale bar in b represents 
100 µm. Data in c, d and f–i are 
presented as mean ± SEM from 
three independent experiments, 
using different cell passages
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mRNA stability (i.e. via miRNA-1228 [57]) or by hybridi-
zation of antisense transcript Wrap53 [29]. Also, in the p53 
promoter, response elements of several transcription fac-
tors [43], [e.g., cAMP-responsive element-binding protein 
(CREB [38])], have been identified. Furthermore, in JAR 
trophoblast cells, p53 was shown to bind to the MMP-2 
promoter in a cAMP-responsive manner [49]. In contrast, 
in our study, we find p53 downregulation upon treatment 
with the cAMP-elevating reagent forskolin and in primary 
trophoblasts undergoing spontaneous differentiation. These 
data indicate a novel, cAMP-independent way of p53 mRNA 
repression in trophoblasts.
The exact role of autophagy in villous trophoblast homeo-
stasis is unclear. Several previous electron microscopy stud-
ies show autophagic vacuoles predominantly in the syncytio-
trophoblast of normal placenta, suggesting autophagy to be 
a constitutive process, which may ensure survival in times 
of moderate nutrient depletion and/or oxidative stress [11]. 
In this context, a study by Broad and Keverne suggests that 
placental autophagy—mainly ribophagy—provides nutrients 
that can be mobilized to protect fetal growth and brain devel-
opment, in situations of acute deprivation [7]. Besides ensur-
ing placental and fetal nutrition, autophagy may represent 
a pivotal mechanism for organelle reorganization required 
after incorporation of cytoplasmic contents of the fusing 
cytotrophoblast into the syncytium. This assumption is based 
on observations in myotube formation, showing dynamic 
remodeling of the mitochondrial network, including mito-
chondrial clearance and biogenesis [15]. Importantly, this 
mitochondrial remodeling is impaired when autophagy is 
inhibited [45]. In the human placenta, mitochondria of the 
syncytiotrophoblast show a different appearance, compared 
to cytotrophoblasts [4]. Thus, autophagy-dependent remod-
eling of the mitochondrial network, as described for myo-
tube formation, may well take place in the syncytioplasm in 
areas of freshly incorporated cytotrophoblasts. Our immu-
nofluorescent and electron microscopy images show a dis-
tinct location in apical cytoplasm of autophagy markers and 
autophagic compartments in the syncytiotrophoblast layer 
in first trimester placentas. Because of this specific proxim-
ity to the maternal circulation, it suggests that autophagy 
might be involved in fetal-maternal communication and/
or transport. However, if these structures are exocytosed to 
release its content into maternal circulation or only used for 
intrasyncytial turnover remains unclear and needs further 
investigation.
In summary, we show that autophagic activity and p53 
levels are reciprocally regulated in villous cytotropho-
blasts and the syncytiotrophoblast. Furthermore, artificially 
maintaining p53 levels reduces autophagy marker LC3B-
II. Thus, our study suggests that differentiation-depend-
ent downregulation of p53 is a prerequisite for activating 
autophagy in the syncytiotrophoblast. Activated autophagy 
may account for organelle and cytoskeleton rearrangement 
during transition from mononucleated into multinucleated 
trophoblast, thereby providing recycled components to the 
syncytiotrophoblast.
Materials and methods
Human placenta tissue samples
The study was approved by the ethical committee of the 
Medical University of Graz. First trimester placental tis-
sues were obtained between weeks 6 and 12 of gestation 
with written informed consent from women undergoing 
legal elective pregnancy terminations. Term placenta tis-
sues were obtained from uncomplicated pregnancies after 
delivery between weeks 38 and 40.
Culture of trophoblast cell lines
BeWo and JAR cells were purchased from the European 
Collection of Cell Cultures (ECACC) and were cultured as 
previously described [18]. In brief, BeWo were cultured in 
DMEM/F12 (1:1, Gibco, life technologies; Paisley, UK) sup-
plemented with 10% FCS (Gibco), penicillin/streptomycin 
(Gibco), amphotericin B (Gibco) and l-glutamine (Gibco) in 
a humidified atmosphere of 5%  CO2 at 37 °C. JAR cells were 
cultured in RPMI medium (Gibco) including same supple-
ments and culture conditions as described for BeWo. Cells 
between passage 10 and 20 were used for in vitro experi-
ments. In case of forskolin treatment, culture medium was 
supplemented with forskolin (Tocris, Bio-techne, Abing-
don, UK) at a final concentration of 20 µM (20 mM stock in 
DMSO). Control cells were incubated with culture medium 
containing the same volume of DMSO (0.1%).
For leupeptin treatments, BeWo cells (2 × 105 cells/
well) were plated in 12-well dishes (Nunc Lab-Tek, Thermo 
Fisher; NY, USA) in above described culture medium 1 day 
prior experimental start. Next day, cells were incubated in 
the presence or absence of forskolin (20 µM) for 48 h at 
37 °C. Leupeptin (Sigma-Aldrich, St. Louis, MO, USA) was 
added to cultures 24 h prior to the end of experiments at 
a concentration of 100 µM. DMSO (0.1%) and aqua dest 
were used as vehicle controls for forskolin and leupeptin, 
respectively.
Isolation and culture of primary term trophoblasts
Primary trophoblasts were isolated from chorionic villi of 
three term placentas with informed consent from women 
with uncomplicated pregnancies and approval by the ethi-
cal committee of the Medical University of Graz. Isolation 
was performed by enzymatic digestion and Percoll density 
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gradient centrifugation as described previously [5]. Tropho-
blasts (3 × 106 cells/well in six well dishes) were cultured 
in DMEM (Gibco, lifetechnologies) with 10% FCS (v/v), 
100 mg/ml streptomycin and 100 IU/ml penicillin (Gibco, 
lifetechnologies). A representative proportion of primary 
cells were scrutinized for purity by immunocytochemistry 
[5] and viability/differentiation was monitored by measure-
ments of secreted human chorionic gonadotropin beta-sub-
unit (βhCG).
LC3B‑GFP experiments
BeWo cells (1.2 × 105 cells/well) were seeded in chamber 
slides (Nunc) 1 day prior experimental start. Next day, cells 
were transfected with 0.5 µg LC3B-GFP vector using K2 
Transfection System (Biontex Laboratories GmbH, Munich, 
Germany), according to the manufacturer’s protocol. After 
24 h, medium was changed and cells were stimulated with 
forskolin (20 µM) or vehicle control DMSO (0.1%) for 48 h 
at 37 °C. Leupeptin (100 µM) was added to cultures for the 
last 4 h of experiments. For live cell imaging of LC3B-GFP 
puncta, cells were washed with PBS and nuclei stained with 
Hoechst 33342 (1:10,000 diluted, Thermo Fisher) for 10 min 
at 37 °C. Twenty randomly selected fields per condition were 
microphotographed (40× objective) using Zeiss Observer 
Z1 inverted microscope (Carl Zeiss, Oberkochen, Germany) 
and the ZEN 2.3 software (Carl Zeiss, blue edition, Version 
2.3.64.0). Quantification of GFP-positive puncta related to 
DAPI signal within an image frame was performed using 
Ilastik Interactive Learning and Segmentation software 
followed by pixel counting with an R script as recently 
described [40].
p53 overexpression experiments
BeWo cells (3 × 105 cells/well) were seeded in 12 well 
dishes in above described culture medium 1 day prior exper-
imental start. Next day, cells were transfected with either 
p53 vector (#10838, 1 µg/well, Addgene; Cambridge, MA, 
USA) or empty vector control using K2 Transfection System 
(Biontex Laboratories GmbH, Munich, Germany), accord-
ing to the manufacturer’s protocol. After 24 h, medium was 
changed and cells were stimulated with forskolin (20 µM) or 
vehicle control DMSO (0.1%) for 48 h. Leupeptin (100 µM) 
was added to cultures 24 h prior to the end of experiments.
Measurement of secreted βhCG
Culture media were collected at indicated time points and 
centrifuged at 4000 rpm for 10 min. Supernatants were 
stored at − 20 °C and subjected in groups to routine immu-
noassay analyses (Dimension Xpand; Dade Behring Inc., 
Deerfield, Illinois).
Placental explant culture
Placental villous tissue from human first trimester was thor-
oughly rinsed in buffered saline and dissected into small 
pieces of approximately 5 mg moist mass as described pre-
viously [46]. Placental explants were cultured in six well 
dishes (Nunc) and 4 ml/well DMEM/F12 supplemented 
with 10% FCS, penicillin/streptomycin, amphotericin B and 
l-glutamine in a hypoxic workstation (BioSpherix; Redfield, 
NY, USA) under 2.5% oxygen for 48 h at 37 °C. For treat-
ments, culture medium was supplemented with Nutlin-3a 
(Cayman chemical, USA) at a working concentration of 
10 µM. DMSO at equal volume was used as vehicle control.
Microarray analyses
Applied Biosystems Human Genome Survey Arrays 
(Applied Biosystems, Foster City, CA, USA) were used to 
determine the transcriptional profiles of BeWo cells treated 
with forskolin (20 µM, 48 h) or DMSO (0.1%, 48 h) as pre-
viously described [18]. Briefly, digoxigenin-UTP labeled 
cRNA was generated and linearly amplified from 30 μg of 
total RNA using Applied Biosystems Chemiluminescent RT-
IVT Labeling Kit. cRNA was fragmented and hybridized to 
the Applied Biosystems Human Genome Survey Microarray 
V2.0 (29,098 genes) and imaged on an AB1700 chemilumi-
nescent microarray analyzer. Gene expression profiles are 
derived from the microarray raw data by quantile normaliza-
tion and averaging of each three replicates. The data set was 
submitted to NCBI gene expression omnibus (Accession #: 
GSE98523).
Genes differentially up- or downregulated more than two-
fold were submitted separately to DAVID functional anno-
tation web tool or to ingenuity pathway analysis (IPA) to 
identify upstream regulators [40].
qPCR analysis
Total RNA was isolated with peqGOLD TriFast (VWR, 
Radnor, Pennsylvania, USA) according to the manufacturer’s 
instructions. Quality check was followed by reverse tran-
scription of 1 µg total RNA per reaction using High-Capac-
ity cDNA Reverse Transcription Kit (Applied Biosystems) 
according to manufacturer’s manual. qPCR was performed 
with Universal SYBR Green Supermix (Bio-Rad, Hercules, 
CA, USA) using a Bio-Rad CFX96 cycler and specific prim-
ers for MAP1LC3B (MAP1LC3B_For: AAG GCG CTT ACA 
GCT CAA TG and MAP1LC3B_Rev: CTG GGA GGC ATA 
GAC CAT GT) and TP53 (TP53_For: CAG CAC ATG ACG 
GAG GTT GT and TP53_Rev: TCA TCC AAA TAC TCC ACA 
CGC) as described previously [39, 40]. Moreover, primers 
for GCM1 (GCM1_For: TTC CCG GTC ACC AAC TTC TG 
and GCM1_Rev: GTA AAC TCC CCT GAC TTT GTGTT), 
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syncytin-1 (ERVW-1_For: CCA TGC CGC TGT ATG ACC AG 
and ERVW-1_Rev: GGG TTC CCT TAG AAA GAC TCCT), 
syncytin-2 (ERVFRD-1_For: ACC GCC ATC CTG ATT TCC 
C and ERVFRD-1_Rev: GAG GCT GGA TAA GCT GTC CC), 
p62 (SQSTM1_For: GAC TAC GAC TTG TGT AGC GTC and 
SQSTM1_Rev: AGT GTC CGT GTT TCA CCT TCC) and hCG 
beta-subunit (CGB_For: TGA GCC ACT CCT GCG CCC and 
CGB_Rev: CAG CCC CTG GAA CAT CTC CA) were used. Ct 
values and relative quantification of gene expression were 
automatically generated by the CFX Manager 2.0 Software 
(Bio-Rad) using the expression of GAPDH (GAPDH_For: 
ACC CAC TCC TCC ACC TTT GA and GAPDH_Rev: CTG 
TTG CTG TAG CCA AAT TCGT) as reference.
Immunoblotting
After incubations, cells and placental explants were washed 
with PBS and homogenized in RIPA buffer (Sigma-Aldrich) 
including protease inhibitor cocktail (Roche Diagnostics; 
Mannheim, Germany). Homogenates were centrifuged at 
8000×g and 4 °C for 10 min. Concentration of total tis-
sue protein was determined in clear supernatants according 
to Lowry method. 30 µg of total protein were applied to 
precast 10% Bis–Tris gels (NuPAGE, Novex; lifetechnolo-
gies). Proteins were blotted on a 0.45-µm nitrocellulose 
membrane (Hybond, Amersham Biosciences, GE Health-
care Life Sciences, Little Chalfont, UK) and blotting effi-
ciency determined with Ponceau staining (Ponceau S solu-
tion, Sigma-Aldrich). Membranes were cut in horizontal 
strips at molecular weight ranges for target proteins. Mouse 
monoclonal anti-p53 antibody (1:2000, clone DO-1, Santa 
Cruz, Dallas, TX, USA), polyclonal LC3B/MAP1LC3B 
antibody (1:1000, NB100-2220, novusbio, Bio-techne), 
polyclonal anti-p62/SQSTM1 antibody (1:1000, #P0067, 
Sigma-Aldrich) and monoclonal anti-beta actin antibody 
(1:20,000; clone AC-15, abcam, Cambridge, UK) were 
applied to membrane strips overnight at 4 °C. HRP conju-
gated goat anti-mouse and goat anti-rabbit IgG (1:3000, Bio-
Rad), respectively, were used as secondary antibodies and 
incubated on membranes for 2 h at RT. Immunodetection 
was performed with a chemiluminescent immunodetection 
kit (Amersham ECL Prime Western blotting detection Rea-
gent) according to the manufacturer´s instructions. Images 
were acquired with FluorChem Q System (Alpha Innotech, 
Cell Bioscienes, Santa Clara, CA, USA) and band densities 
were analyzed with Li-Cor Image Studio Lite 5.2. Results 
are presented as a ratio of target protein and beta-actin band 
densities.
Immunofluorescence
Morphological evaluation of syncytialization was performed 
by staining transmembrane protein E-cadherin to visualize 
cell borders. For this purpose, BeWo and JAR cells (8 × 104 
cells/chamber) were seeded in chamber slides and incubated 
with either forskolin (20 µM) or vehicle control (DMSO, 
0.1%) for 48 h. Thereafter, cells were washed with PBS, 
dried and fixed in acetone for 10 min. Rehydration with 
PBS was followed by incubation with Ultra Vision Protein-
Block (LabVision, Thermo Fisher Scientific, Runcorn, UK) 
for 7 min. Monoclonal anti-E-Cadherin antibody (Acris 
Antibodies GmbH, OriGene EU, Herford, Germany) was 
diluted 1:15 in antibody diluent (DAKO, Carpintera, CA, 
USA) and incubated on cells for 30 min. PBS washing steps 
were followed by incubation with secondary antibody, Alexa 
Fluor 555 goat anti-mouse (1:200; Invitrogen, Lifetechnolo-
gies, Carlsbad, CA, USA) for 30 min. Slides were washed 
and nuclei were stained with DAPI (1:2000; Invitrogen) for 
5 min.
For p53 and LC3B double fluorescence, formalin fixed 
and paraffin embedded (FFPE) human first trimester (n = 3) 
was cut in 5 µm sections and mounted on Superfrost Plus 
slides (Menzel/Thermo Fisher Scientific; Braunschweig, 
Germany). Standard deparaffinization was followed by 
boiling sections in 10 mM sodium citrate buffer (pH 6.0) 
for antigen retrieval. Slides were incubated with anti-p53 
antibody (1:50, clone DO-X, Santa Cruz) and anti-LC3 anti-
body (1:5000, NB100-2220, novusbio) for 45 min. Subse-
quently, slides were washed and incubated with a mixture of 
Alexa Fluor 555 goat anti-rabbit and Alexa Fluor 488 goat 
anti-mouse antibodies (both 1:200, Invitrogen) for 30 min 
at room temperature. Slides were washed and nuclei were 
stained with DAPI (1:2000; Invitrogen). For negative con-
trols, negative control for rabbit IgG (Ab-1, Thermos Fisher 
Scientific) and negative control mouse IgG2a (DAKO) were 
used and generated no staining. After staining, cells as well 
as tissue sections were mounted with ProLong Gold anti-
fade reagent (Invitrogen). Fluorescence microscopy was 
performed using a Zeiss Observer Z1 inverted microscope 
(Carl Zeiss, Oberkochen, Germany).
Immunohistochemistry and immunocytochemistry
Human first trimester (n = 5) and term FFPE placental tis-
sue (n = 5) sections (5 μm) were mounted on Superfrost 
Plus slides. After deparaffinization slides were subjected 
to antigen retrieval by boiling sections in 10 mM sodium 
citrate buffer (pH 6.0) for 7 min at 120 °C. Sections were 
stained using the UltraVision Large Volume Detection Sys-
tem HRP Polymer Kit (Thermo Fisher Scientific) as pre-
viously described [47]. In brief, endogenous peroxidase 
was blocked with UltraVision hydrogen peroxide block for 
10 min. Three washing steps with TBS including 0.05% 
Tween 20 (TBS/T; Merck; Darmstadt, Germany) were fol-
lowed by Ultra Vision Protein Block for 5 min. Monoclo-
nal anti-p53 antibody (1:50, clone DO-1, Santa Cruz) was 
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diluted in Antibody Diluent (DAKO) and incubated on slides 
for 45 min at RT. After three TBS/T washing steps detection 
was achieved by incubation with primary antibody enhancer 
and a HRP-labeled polymer system (15 min) and 3-amino-
9-ethylcarbazole (AEC, Thermo Scientific), according to 
the manufacturer’s instructions. Nuclei were stained with 
hemalaun and slides were mounted with Kaiser’s glycerol 
gelatine (Merck). P62 staining was performed as described 
above, using antigen retrieval buffer pH 9.0 and polyclonal 
anti-p62/SQSTM1 antibody (1:10,000, Sigma-Aldrich).
For immunocytochemistry, BeWo cells were seeded in 
chamber slides (8 × 104/chamber) and were stimulated with 
forskolin (20 µM) or vehicle control DMSO (0.1%) for 48 h. 
After culture, cells were washed with PBS, dried and fixed in 
acetone for 10 min. Rehydration with PBS was followed by 
p53 staining procedure as described for immunohistochemis-
try, except antigen retrieval procedure. For negative control, 
slides were incubated with negative control mouse IgG2a 
at the same concentration as for anti-p53 antibody. Images 
were acquired with a Leica microscope (Leica DM6000B) 
and a digital camera (Olympus DP72).
Transmission electron microscopy
For transmission electron microscopy, first trimester pla-
centa was fixed in 0.1 M phosphate buffer (pH 7.4) con-
taining 2.5% glutaraldehyde and 2% formaldehyde (2 h), 
post-fixed in 2% OsO4 (2 h), dehydrated in graded series 
of ethanol, and embedded in a TAAB epoxy resin (Gröpl). 
Ultrathin sections (75 nm) were cut with a Leica UC 7 and 
stained with lead citrate and platine blue. Images were taken 
on a FEI Tecnai G2 20 transmission electron microscope 
(FEI, Eindhoven, the Netherlands) with a Gatan ultrascan 
1000 CCD camera (acceleration voltage 120 kV.
Quantification of p53 immunostaining in BeWo cells
Imaging was performed on a Leica Microscope with 20× 
magnification and 24 or 32 randomly selected fields per sam-
ple. Quantification of immunostaining was performed with 
the open-source cell image analysis software CellProfiler 
(Version 2.1.1) [9]. The pipeline was designed for quanti-
fication of AEC staining within the cell nucleus. In short, 
images were processed with the “Identify Primary Objects” 
modules to identify cell nuclei and AEC stained regions. 
Nuclei areas were applied as mask using the “Mask Image” 
module, thereby defining a positive region for quantification 
of AEC staining. We used the “Measure Image Intensity” 
module to quantify AEC intensity with size threshold of 
5–1000 pixels with lower and upper intensity threshold of 
0.6–1.0. For each image, total AEC pixel intensity values 
were divided through the nuclear pixel area.
Statistical analysis
Data were analyzed using SigmaPlot 12.5 and are pre-
sented as mean ± SEM. Data were subjected to normality 
test (Shapiro–Wilk test) and equal variance test. In case of 
normally distributed data differences between groups were 
tested using two-tailed t test. Otherwise, Mann–Whitney 
rank sum test was applied. For multiple comparison pro-
cedure, one-way repeated measures analysis of variance 
was followed by Holm–Sidak method to isolate groups 
that differ from the others. One sample t test was used 
when controls were set as 1. A p value of less than 0.05 
was considered statistically significant.
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